Investigating synergism of Mcl-1 inhibition with first line therapies for leukaemia

被引：0
|
作者：
Cosimo, E. [1 ]
Ball, R. J. [1 ]
Couves, A. [1 ]
Allan, E. K. [1 ]
Jorgensen, H. G. [1 ]
Michie, A. M. [1 ]
机构：
[1] Univ Glasgow, Inst Canc Sci, Paul OGorman Leukaemia Res Ctr, Glasgow, Lanark, Scotland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 157卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
148
引用
收藏
页码：57 / 58
页数：2
相关论文
共 50 条
  • [1] Allosteric inhibition of antiapoptotic MCL-1
    Susan Lee
    Thomas E Wales
    Silvia Escudero
    Daniel T Cohen
    James Luccarelli
    Catherine G Gallagher
    Nicole A Cohen
    Annissa J Huhn
    Gregory H Bird
    John R Engen
    Loren D Walensky
    Nature Structural & Molecular Biology, 2016, 23 : 600 - 607
  • [2] MCL-1 inhibition in cancer treatment
    Xiang, Weiguo
    Yang, Chao-Yie
    Bai, Longchuan
    ONCOTARGETS AND THERAPY, 2018, 11 : 7301 - 7314
  • [3] Allosteric inhibition of antiapoptotic MCL-1
    Lee, Susan
    Wales, Thomas E.
    Escudero, Silvia
    Cohen, Daniel T.
    Luccarelli, James
    Gallagher, Catherine G.
    Cohen, Nicole A.
    Huhn, Annissa J.
    Bird, Gregory H.
    Engen, John R.
    Walensky, Loren D.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2016, 23 (06) : 600 - 607
  • [4] DEXAMETHASONE PROVIDES POTENTIAL SYNERGISM WITH MCL-1 ANTAGONIST IN AML
    Bohl, Stephan R.
    Estill, Peter
    Minihane, Emma
    MacDonald, Julie
    McQueeney, Kelley
    Ryan, Jeremy
    Letai, Anthony
    ANNALS OF HEMATOLOGY, 2023, 102 (SUPPL 1) : S68 - S68
  • [5] Modelling MCL-1 inhibition in breast cancer
    Campbell, Kirsteen
    Dhayade, Sandeep
    Ferrari, Nicola
    Johnson, Emma
    Hair, Jane
    Edwards, Joanne
    Tait, Stephen
    Blyth, Karen
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 185 - 185
  • [6] BRAF/MEK inhibitors selectively prime melanoma for Mcl-1 dependence and sensitize to Mcl-1 inhibition
    Kump, Karson J.
    Miao, Lei
    Ansari, Nurul
    Lombard, David B.
    Nikolovska-Coleska, Zaneta
    CANCER RESEARCH, 2019, 79 (13)
  • [7] Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
    Al-Odat, O. S.
    von Suskil, M.
    Chitren, R. J.
    Elbezanti, W. O.
    Srivastava, S. K.
    Budak-Alpddogan, T.
    Jonnalagadda, S. C.
    Aggarwal, B. B.
    Pandey, M. K.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
    Al-Odat, Omar
    von Suskil, Max
    Chitren, Robert
    Elbezanti, Weam
    Srivastava, Sandeep
    Budak-Alpddogan, Tulin
    Jonnalagadda, Subash
    Aggarwal, Bharat
    Pandey, Manoj
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [9] Synergism between p53 and Mcl-1 in hepatocyte maturation and survival
    Weng, Shih-Yen
    Hsiao, Michael
    Huang, Pei-Hsin
    Tao, Mi-Hua
    Yang-Yen, Hsin-Fang
    Yang, Chia-Yu
    Li, Chao-Chin
    Sun, Te-Ping
    Tung, Shu-Yun
    Yen, Jeffrey Jong-Young
    Tsai, Ting-Fen
    Chen, Chun-Ming
    Chen, Sung Ho
    CANCER RESEARCH, 2011, 71
  • [10] Inhibition of XPO1 enhances cell death induced by ABT-199 in acute myeloid leukaemia via Mcl-1
    Luedtke, Daniel A.
    Su, Yongwei
    Liu, Shuang
    Edwards, Holly
    Wang, Yue
    Lin, Hai
    Taub, Jeffrey W.
    Ge, Yubin
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (12) : 6099 - 6111
12345